#CRNX announces second quarter financial results and provides a business update for 2025. Learn more: https://bit.ly/4llrqNj
Crinetics Pharmaceuticals
Biotechnology Research
San Diego, California 36,600 followers
Discovering drugs for endocrine diseases and endocrine-related tumors. #acromegaly #crinetics #CarcinoidSyndrome
About us
Our mission is to build the leading endocrine company that consistently pioneers new therapeutics to help patients better control their disease and improve their daily lives. Working to accomplish this mission is how we bring our vision to life. For us, that vision is the best possible therapeutics available to all patients with diseases of the endocrine system. We love how that sounds. And we really can’t wait to know how it feels. Notice of Fraudulent Activity for Job Applicants: Please be aware of fraudulent communications from job posting sites or email. Bad actors may try to impersonate Crinetics’ Talent Acquisition team, and their messages may appear legitimate. We strongly recommend you verify all communications you receive about positions at Crinetics. If you are unsure about a posting or email you receive, please contact us at talentacquisition@crinetics.com.
- Website
-
https://crinetics.com
External link for Crinetics Pharmaceuticals
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- San Diego, California
- Type
- Public Company
- Founded
- 2008
- Specialties
- Drug Discovery, Endocrinology, RareDisease, and Biotech
Locations
-
Primary
Get directions
6055 Lusk Blvd
San Diego, California 92121, US
Employees at Crinetics Pharmaceuticals
Updates
-
Our HEOR team’s work on acromegaly will be featured in an upcoming webinar hosted by The Evidence Base, spotlighting real-world evidence on burden and treatment gaps. Tiffany Quock, PhD, MS, will join as a speaker. Register here: https://bit.ly/3J7htWn
Welcome to our new spotlight on The Evidence Base, showcasing the use of #RWE to better understand treatment and dosing patterns associated with #RareDiseases, with a focus on #acromegaly. Visit here >> ➡️ https://lnkd.in/eHD_7dMw and access peer-reviewed research, webinars and other resources. In partnership with Crinetics Pharmaceuticals and ADVI Health. #heor #healtheconomics #outcomesresearch #healthoutcomes #RealWorldEvidence #rwd #realworldevidence #healthdata #orphandrugs #claimsdata
-
-
Meet the true leader behind our people operations – Coco, the faithful companion to our Chief Human Resources Officer, Adriana Cabré. Together, they foster our unique company culture and ensure that we attract the very best two-legged AND four-legged talent! Want to learn more about our dog-friendly culture? https://bit.ly/3BmigiR #CrineticsCanines #DogsAtWork #BiotechCareers
-
-
Join us tomorrow with Dr. Shlomo Melmed of Cedars-Sinai for a virtual discussion exploring the progressive nature of acromegaly and its daily impact on patients. The session will address challenges in diagnosis, symptom burden and the complexities of long-term management. Register here: https://bit.ly/45BP18n
-
-
A new 4-paper series authored by Crinetics researchers is now publishing in the Journal of Comparative Effectiveness Research. The series has been selected for the journal’s “Real-World Evidence in the Spotlight” webinar on July 31. Register for the webinar here: https://lnkd.in/eqZmiMvV
-
-
We’d like to extend our congratulations to Dr. Wierenga, Chairman of the Crinetics Board of Directors, as he’s been recognized as Director of the Year in the Companies in Transition Category by Corporate Directors Forum! With 40+ years of leadership in research, drug discovery, and drug development, and a hand in bringing 16 therapies to market, Dr. Wierenga’s guidance continues to be pivotal as we advance toward our mission of becoming the world’s leading endocrinology company. #DirectorOfTheYear
Announcing the 2025 Director of the Year Honorees. Corporate Directors Forum is proud to recognize this year’s outstanding boar members—visionaries whose impact spans industries, communities, and boardrooms. Please join us in celebrating: - Dr. Enoch Kariuki, Pharm.D. – Corporate Governance - Lara L. Lee – Enhancement of Culture & Inclusion - Dr. Wendell Wierenga, Ph.D. – Companies in Transition - Vickie Turner – Emerging Board Leader - Martha Gilmer – Not-for-Profit Board Governance - Mitch Mitchell – Impact Award - Rich Sulpizio – Lifetime Achievement Award These leaders exemplify the values of effective governance, strategic vision, and commitment to service. Mark your calendar for October 7, 2025, as we honor them at the 2025 Director of the Year Awards. Learn more: https://lnkd.in/g-ZPSB7k . . . #CorporateGovernance #BoardLeadership #DirectorOfTheYear #CDF #ExecutiveLeadership #SanDiegoEvents #CorporateDirectorsForum
-
-
-
-
-
+4
-
-
Thank you to everyone who joined us at #ENDO2025. We were proud to present new data supporting our mission to advance care in endocrinology. Swipe to see highlights from the event!
-
Live from #ENDO2025: Dr. Raffaella Colzani shares how receptor biology is opening new doors.
-
Live from #ENDO2025: What’s changing in endocrinology — and why now? Robert M. Cuddihy, MD, F.A.C.E. shares his take on where endocrinology is headed, and how patient voices are shaping clinical development in new ways.
-
Live from #ENDO2025: Cushing’s is complex — Antonio Ribeiro-Oliveira Jr, MD, PhD, BCMAS explains why. Hear his candid look at a complex condition.